[Federal Register Volume 62, Number 244 (Friday, December 19, 1997)]
[Notices]
[Pages 66631-66632]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-33097]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration


Advisory Committee Information Line

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) has changed its 
procedure for accessing the Advisory Committee Information Line (the 
information line) concerning those advisory committees under the 
purview of the Center for Biologics Evaluation and Research (CBER). 
CBER has assigned a separate 5-digit code to each of its advisory 
committees.

FOR FURTHER INFORMATION CONTACT: Donna M. Combs, Committee Management 
Office (HFA-306), Food and Drug Administration, 5600 Fishers Lane, 
Rockville, MD 20857, 301-827-4820.

SUPPLEMENTARY INFORMATION: The information line provides the public 
with access to the most current information available on upcoming FDA 
advisory committee meetings, guidance for making an oral presentation 
during the open public hearing portion of an advisory committee 
meeting, and procedures for obtaining copies of transcripts of advisory 
committee meetings. The information line can be accessed by dialing 1-
800-741-8138 or 301-443-0572. Each advisory committee has been assigned 
a 5-digit code on the information line that enables the public to 
obtain information about a particular advisory committee by using that 
code. This 5-digit code appears in each individual notice of a meeting. 
Information provided is preliminary and may change before a meeting is 
held. The information line will be updated when such changes are made. 
The following is a list of CBER's advisory committees and the 5-digit 
code assigned to each advisory committee:

                                                                        
------------------------------------------------------------------------
           Committee name                            Code               
------------------------------------------------------------------------
Allergenic Products Advisory                                            
 Committee.........................                               12388 
Biological Response Modifiers                                           
 Advisory Committee................                               12389 
Blood Products Advisory Committee..                               19516 

[[Page 66632]]

                                                                        
Vaccines and Related Biological                                         
 Products Advisory Committee.......                               12391 
Transmissible Spongiform                                                
 Encephalopathies Advisory                                              
 Committee.........................                               12392 
------------------------------------------------------------------------


    Dated: December 11, 1997.
Michael A. Friedman,
Deputy Commissioner for Operations.
[FR Doc. 97-33097 Filed 12-18-97; 8:45 am]
BILLING CODE 4160-01-F